Notice of Intent: Measuring AAV9 vector DNA in mice tissue using qPCR

AI Summary: This solicitation requests small businesses to submit capability statements demonstrating their ability to perform mouse tissue histology processing and histopathology staining, as well as AAV9 antibody screening of mouse serum samples for a preclinical trial involving gene editing therapy in mice with Hutchinson Gilford Progeria Syndrome. The work is located at the National Institutes of Health's Bethesda facility in Maryland and does not set aside opportunities for specific types of businesses; however, eligible small business types are encouraged to submit statements supporting their capability to perform these tasks.

Opportunity Details

Solicitation Number: 75N98027Q00015

Date Added: October 16, 2026

Description:

https://api.sam.gov/prod/opportunities/v1/noticedesc?noticeid=e946fe114669489e9d2e52a37f0bc34b

Set-Aside: No Set aside used (NONE)

Place of Performance: Bethesda, Maryland, UNITED STATES

NAICS Codes:
541380

Files:

https://sam.gov/api/prod/opps/v3/opportunities/resources/files/89f6013a9e474c77bcdb73674d19569a/download

Notice of Intent: Measuring AAV9 vector DNA in mice tissue using qPCR

Opportunity Details

Here are other similar opportunities for you

J065--RO Equipment Maintenance

H966--MONTHLY VIABLE SURFACE SAMPLING

Groundwater Monitoring in Wabasha County, MN

Stability Testing for ManNAc Drug Product produced in Campaigns 5 and 6. Stabil…